Covid-19 Info:
We keep delivering!
We have COVID-19 Safety Plan and are committed to keeping you safe.
Dosage Form | |
---|---|
Strength | 15 mg, 45 mg |
Generic Names | |
Manufacturer |
Ponatinib is a kinase inhibitor. Ponatinib inhibited the in vitro tyrosine kinase activity of ABL and T315I mutant ABL with IC 50 concentrations of 0.4 nM and 2.0 nM, respectively. Ponatinib inhibited the in vitro activity of additional kinases with IC 50 concentrations between 0.1 nM and 20 nM, including members of the VEGFR, PDGFR, FGFR, EPH receptors and SRC families of kinases, and KIT, RET, TIE2, and FLT3. Ponatinib inhibited the in vitro viability of cells expressing native or mutant BCR-ABL, including T315I. In mice, treatment with ponatinib reduced the size of tumors expressing native or T315I mutant BCR-ABL when compared to controls.
৳ 656.60 – ৳ 1,937.60
Dosage Form | |
---|---|
Strength | 15 mg, 45 mg |
Generic Names | |
Manufacturer |
Search from thousands of medicine and health products for your daily needs. Preskriptionpoint will ship them to your door with our fastest facility.
Accounts
Stop! This is a test environment, not a live site yet. please wait until the final publication for any order.
Something isn’t Clear?
Feel free to contact us, and we will be more than happy to answer all of your questions.
Covid-19:
We keep delivering!